Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver malignancy and is increasing in incidence. Long-term outcomes are optimized when patients undergo margin-negative resection followed by adjuvant chemotherapy. Unfortunately, a significant proportion of patients present wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Akateh, Clifford, Ejaz, Aslam M, Pawlik, Timothy Michael, Cloyd, Jordan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643214/
https://www.ncbi.nlm.nih.gov/pubmed/33200010
http://dx.doi.org/10.4254/wjh.v12.i10.693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643214/
https://www.ncbi.nlm.nih.gov/pubmed/33200010
http://dx.doi.org/10.4254/wjh.v12.i10.693

Ejemplares similares